Citius Oncology CTOR
NASDAQ CTOR
$0.56 0.00 (-0.71%)
As of: Nov 11, 2026 · 3:59 PM EST

Citius Oncology (CTOR) Interest Paid (2025 - 2026)

Updated

Citius Oncology's Interest Paid was $198,334 in fiscal Q3 2026 (quarter ended Jun 30, 2026).

Analysis

Citius Oncology (CTOR) Interest Paid (2025 - 2026) Analysis & Trends

For FY2025 (ended Sep 30, 2025), Interest Paid at Citius Oncology came in at $187,389.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Paid (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -1.78 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 283.00 Mn
10 Citius Oncology 60.42 Mn 30.00 Mn 1.00 Mn 198,334.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 198,334.00
Dec 31, 2025 14,460.00
API Access

Citius Oncology Interest Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-paid&ticker=CTOR&period=max&api_key=YOUR_API_KEY